Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to Energesis Pharmaceuticals

List of SBIR/STTR awards granted to Energesis Pharmaceuticals

List of SBIR/STTR awards granted to Aerobotix

List of SBIR/STTR awards granted to APOLLO INSTRUMENTS, INC.

List of SBIR/STTR awards granted to PolyNew, Inc

List of companies in BlockVC's investment portfolio

List of companies in Viola Ventures (formerly Carmel Ventures)'s investment portfolio

where

SBIR/STTR Award Recipient

is

‌

Energesis Pharmaceuticals

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ ENERGESIS PHARMACEUTICALS, INC. SBIR Phase I Award, July 2020	A SBIR Phase I contract was awarded to Energesis Pharmaceuticals in July, 2020 for $295,420.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Energesis Pharmaceuticals		National Institutes of Health	SBIR	1R43DK125193-01A1	Phase I	295,420	July 1, 2020	sbir.gov/node/1916061
	‌ ENERGESIS PHARMACEUTICALS, INC. SBIR Phase II Award, August 2021	A SBIR Phase II contract was awarded to Energesis Pharmaceuticals in August, 2021 for $1,018,644.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Energesis Pharmaceuticals		National Institutes of Health	SBIR	2R44DK125193-02	Phase II	1,018,644	August 1, 2021	sbir.gov/node/2191643
	‌ ENERGESIS PHARMACEUTICALS, INC. SBIR Phase II Award, June 2016	A SBIR Phase II contract was awarded to Energesis Pharmaceuticals in June, 2016 for $1,781,519.0 USD from the U.S. Department of Health & Human Services.	‌ Energesis Pharmaceuticals			SBIR	1R44DK109860-01	Phase II	1,781,519	June 20, 2016	sbir.gov/node/1165307
	‌ ENERGESIS PHARMACEUTICALS, INC. SBIR Phase II Award, July 2015	A SBIR Phase II contract was awarded to Energesis Pharmaceuticals in July, 2015 for $998,628.0 USD from the U.S. Department of Defense.	‌ Energesis Pharmaceuticals	U.S. Department of Defense		SBIR	W81XWH-15-C-0090	Phase II	998,628	July 20, 2015	sbir.gov/node/976545
	‌ ENERGESIS PHARMACEUTICALS, INC. SBIR Phase II Award, September 2017	A SBIR Phase II contract was awarded to Energesis Pharmaceuticals in September, 2017 for $1,775,542.0 USD from the U.S. Department of Health & Human Services.	‌ Energesis Pharmaceuticals			SBIR	1R44DK113877-01A1	Phase II	1,775,542	September 18, 2017	sbir.gov/node/1324453
	‌ ENERGESIS PHARMACEUTICALS, INC. STTR Phase II Award, September 2012	A STTR Phase II contract was awarded to Energesis Pharmaceuticals in September, 2012 for $749,692.0 USD from the U.S. Department of Defense.	‌ Energesis Pharmaceuticals	U.S. Department of Defense		STTR	W81XWH-11-C-0517	Phase II	749,692	September 15, 2012	sbir.gov/content/human-brown-adipocyte-transplantation-and-vivo-metabolic-characterization-0
	‌ ENERGESIS PHARMACEUTICALS, INC. STTR Phase I Award, October 2011	A STTR Phase I contract was awarded to Energesis Pharmaceuticals in October, 2011 for $98,942.0 USD from the U.S. Department of Defense.	‌ Energesis Pharmaceuticals	U.S. Department of Defense		STTR	W81XWH-11-C-0517	Phase I	98,942	October 3, 2011	sbir.gov/node/377157
	‌ ENERGESIS PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Energesis Pharmaceuticals for $276,203.0 USD from the U.S. Department of Health & Human Services.	‌ Energesis Pharmaceuticals			SBIR	1R43DK101205-01	Phase I	276,203		sbir.gov/node/705587
	‌ ENERGESIS PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Energesis Pharmaceuticals for $168,876.0 USD from the U.S. Department of Health & Human Services.	‌ Energesis Pharmaceuticals			SBIR	1R43DK099005-01	Phase I	168,876		sbir.gov/node/677818

9 results

0 selected

9 results

0 selected